This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovations of Daniel Skomski
Introduction
Daniel Skomski is an accomplished inventor based in East Brunswick, NJ (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target HIV.
Latest Patents
Skomski holds a patent for "Crystalline forms of an NRTTI compound." This patent provides novel anhydrate crystalline Forms 1 and 4 of 4'-Ethynyl-2-fluoro-2′-deoxyadenosine. These forms may be useful for inhibiting HIV reverse transcriptase and for the treatment or prophylaxis of HIV infection, as well as for delaying the onset or progression of AIDS or ARC. He has 1 patent to his name.
Career Highlights
Daniel Skomski is currently employed at Merck Sharp & Dohme Corp., a leading global healthcare company. His work focuses on innovative solutions to combat viral infections, showcasing his commitment to improving public health.
Collaborations
Throughout his career, Skomski has collaborated with notable colleagues, including Marko Cubrovic and Stephanie Elizabeth Barrett. These partnerships have contributed to the advancement of his research and the development of effective pharmaceutical solutions.
Conclusion
Daniel Skomski's contributions to the field of pharmaceuticals, particularly in the fight against HIV, highlight his innovative spirit and dedication to improving health outcomes. His work continues to inspire advancements in medical research and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile